Two cell lines were selected, the HER2+ve cell line SKBR-3 that massively overexpresses Grb7 along with HER2, and MDA-MB-231 that is a triple negative breast cancer cell (TNBC) line that expresses only low levels of Grb7. This evidence concerns the gene GRB7 and triple-negative breast carcinoma.